A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...